UBS


27/01/21 -"Strong Q4 20 and FY 2020 figures which were clearly above consensus and our expectations. UBS was a winner of the COVID-19 turmoil in 2020, especially the Investment Bank. We have therefore upgraded ..."

Pages
51
Language
English
Published on
27/01/21
You may also be interested by these reports :
26/02/21
• Net profit decreased by 47% to €783m for 2020 • Loan loss provisions were €1.3bn for 2020 compared to €39m for 2019 due to COVID-19 burdens • RoTE ...

25/02/21
As announced in our post-release comments, we have upgraded our forecasts driven by lower loan impairments and increased cost savings. Hence, we have ...

25/02/21
The group posted a mixed set of results, showing a net interest margin recovery but also subdued capital market revenues. Without the help of ...

24/02/21
The lockdowns continued to weigh on the top-line performance, but the state’s supporting measures have proven so successful that the quarter enjoyed ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO